On Friday the 28th of July, the U.S. Food and Drug Administration (FDA), announced a new comprehensive plan for tobacco and nicotine regulation, under which the much disputed PreMarket Tobacco Applications (PMTA), will be delayed for four years until 2022. However although a start, this motion is far from perfect. The extension only applies to … Continue reading Reactions to the FDA’s tobacco plan announcement